Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Asakawa H, Nishikimi T, Suzuki T, Hara S, Tsubokou Y, Yagi H, Yabe A, Tsuchiya N, Horinaka S, Kangawa K, Matsuoka H. (2001) Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty. Clin Sci. 100:117–126.
Dobrzynski E, Wang C, Chao J, Chao L. (2000) Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 36:995–1001.
Hasegawa H, Mizuhira V, Notoya M, Inazawa K, Mizojir K, Kitamura K, Kangawa K. (1998) Autoradiographic studies on the binding sites of 125I-adrenomedullin in rat tissues. Acta Histochem Cytochem 31:335–343
Hirayama N, Kitamura K, Imamura T, Kato J, Koiwaya Y, Tsuji T, Kangawa K, Eto T. (1999) Molecular forms of circulating adrenomedullin in patients with congestive heart failure. J Endocrinol. 160:297–303.
Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. (1999) Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur J Pharmacol. 382:1–9.
Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. (1994) Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest. 94:2158–2161.
Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T. (1993) Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 241:271–273.
Jougasaki M, Wei CM, McKinley LJ, Bumett JC Jr. (1995) Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 92:286–289.
Kakishita M, Nishikimi T, Okano Y, Satoh T, Kyotani S, Nagaya N, Fukushima K, Nakanishi N, Takishita S, Miyata A, Kangawa K, Matsuo H, Kunieda T. (1999) Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci. 96:33–39.
Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T. (1996) Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab. 81:180–183.
Kato J, Kitamura K, Matsui E, Tanaka M, Ishizaka Y, Kita T, Kangawa K, Eto T. (1999) Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension. Hypertens Res. 22:61–65.
Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, Eto T. (2002) Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res. 25:887–892.
Katoh F, Niina H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K, Eto T, Wada A. (1994) Ca(2+)-dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett. 348:61–64.
Kato K, Kitamura K, Kuwasako K, Tanaka M, Ishiyama Y, Shimokubo T, Ichiki Y, Nakamura S, Kangawa K, Eto T. (1995) Plasma adrenomedullin in patients with primary aldosteronism. Am J Hypertens. 8:997–1000.
Khan AI, Kato J, Kitamura K, Kangawa K, Eto T. (1997a) Hypotensive effect of chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 24:139–142.
Khan AI, Kato J, Ishiyama Y, Kitamura K, Kangawa K, Eto T. (1997b) Effect of chronically infused adrenomedullin in two-kidney, one-clip hypertensive rats. Eur J Pharmacol. 333:187–190.
Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, and Eto T. (1993a) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Bioche Biophys Res Commun. 192:553–560.
Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. (1993b) Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun. 194:720–725.
Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H, Eto T. (1994) Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett. 338:306–310.
Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, Eto T. (1998) The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun. 244:551–555.
Kobayashi K, Kitamura K, Etoh T, Nagatomo Y, Takenaga M, Ishikawa T, Imamura T, Koiwaya Y, Eto T. (1996a) Increased plasma adrenomedullin levels in chronic congestive heart failure. Am Heart J. 131:994–998.
Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, Hanada Y, Nagatomo Y, Takenaga M, Ishikawa T, Imamura T, Koiwaya Y, Eto T. (1996b) Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J. 131:676–680.
Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, Minami M, Yasunari K, Yoshikawa J. (1996) Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27:102–107.
Lewis LK, Smith MW, Brennan SO, Yandle TG, Richards AM, Nicholls MG. (1997) Degradation of human adrenomedullin(1–52) by plasma membrane enzymes and identification of metabolites. Peptides. 18:733–739.
Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG. (1998) Adrenomedullin(1–52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem. 44:571–577.
Lisy O, Jougasaki M, Schirger JA, Chen HH, Barclay PT, Bumett JC Jr. (1998) Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin. Am J Physiol. 275:F410–F414.
Meeran K, O’Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR. (1997) Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab. 82:95–100.
Minami J, Nishikimi T, Todoroki M, Kashiwakura C, Yagi H, Ono H, Horinaka S, Ishimitsu T, Kangawa K, Matsuoka H. (2002) Source of plasma adrenomedullin in patients with pheochromocytoma. Am J Hypertens. 15:994–997.
Miyao Y, Nishikimi T, Goto Y, Miyazaki S, Daikoku S, Morii I, Matsumoto T, Takishita S, Miyata A, Matsuo H, Kangawa K, Nonogi H. (1998) Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart. 79:39–44.
Mori Y, Nishikimi T, Kobayashi N, Ono H, Kangawa K, Matsuoka H. (2002) Long-term adrenomedullin infusion improves survival in malignant hypertensive rats. Hypertension. 40:107–113.
Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, Dohi K, Kangawa K.(1999) Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension. 33:1146–1152.
Nagaya N, Nishikimi T, Uematsu M, Yoshitomi Y, Miyao Y, Miyazaki S, Goto Y, Kojima S, Kuramochi M, Matsuo H, Kangawa K, Nonogi H. (1999) Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart. 81:483–487.
Nagaya N, Nishikimi T, Uematsu M, Satoh T, Oya H, Kyotani S, Sakamaki F, Ueno K, Nakanishi N, Miyatake K, Kangawa K. (2000) Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart. 84:653–658.
Nagaya N, Goto Y, Satoh T, Sumida H, Kojima S, Miyatake K, Kangawa K. (2002) Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol. 39:754–760.
Nakamura R, Kato J, Kitamura K, Onitsuka H, Imamura T, Marutsuka K, Asada Y, Kangawa K, Eto T. (2002) Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats. Cardiovasc Res. 56:373–380.
Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, Takamiya M, Kangawa K, Matsuo H, Eto T, Omae T, Matsuoka H. (1994) Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension. 24:600–604.
Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. (1995) Increased plasma levels of adrenomedullin in patients with heart failure. JAm Coll Cardiol. 26:1424–1431.
Nishikimi T, Matsuoka H, Ishikawa K, Yoshihara F, Kawano Y, Kitamura K, Saito Y, Kangawa K, Matsuo H, Omae T. (1996) Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. Hypertens Res. 19:97–101.
Nishikimi T, Nagata S, Sasaki T, Tomimoto S, Matsuoka H, Takishita S, Kitamura K, Miyata A, Matsuo H, Kangawa K. (1997) Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart. 78:390–395.
Nishikimi T, Matsuoka H, Shimada K, Matsuo H, Kangawa K. (2000) Production and clearance sites of two molecular forms of adrenomedullin in human plasma. Am J Hypertens. 13:1032–1034.
Nishikimi T, Horio T, Kohmoto Y, Yoshihara F, Nagaya N, Inenaga T, Saito M, Teranishi M, Nakamura M, Ohrui M, Kawano Y, Matsuo H, Ishimitsu T, Takishita S, Matsuoka H, Kangawa K. (200la) Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J Hypertens 19:765–773.
Nishikimi T, Nagata S, Sasaki T, Yoshihara F, Nagaya N, Horio T, Matsuo H, Matsuoka H, Kangawa K. (2001b) The active molecular form of plasma adrenomedullin is extracted in the pulmonary circulation in patients with mitral stenosis: possible role of adrenomedullin in pulmonary hypertension. Clin Sci. 100:61–66.
Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara F, Kangawa K, Matsuoka H. (2002) Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension. 39:1077–1082.
Nishikini T, Tadokoro K, Mori Y, Wang X, Akimoto K, Yoshihara F, Minamino N, Kangawa K, Matsuoka H. (2003) Ventricular adrenomedullin system in the transition from LVH to heart failure in rats. Hypertension. 41:512–518.
Ohta H, Tsuji T, Asai S, Tanizaki S, Sasakura K, Teraoka H, Kitamura K, Kangawa K. (1999) A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin Chim Acta. 287:131–143.
Ohta H, Tsuji T, Asai S, Sasakura K, Teraoka H, Kitamura K, Kangawa K. (1999) One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. ClinChem. 45:244–251.
Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yutani C, Kangawa K. (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation. 109:242–248.
Pousset F, Masson F, Chavirovskaia O, Isnard R, Carayon A, Golmard JL, Lechat P, Thomas D, Komajda M. (2000) Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J. 21:1009–1014.
Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Tumer JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW. (1998) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1921–1929.
Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T. (1996) Adrenomedullin: changes in circulating and cardiac tissue concentration in Dahl salt-sensitive rats on a high-salt diet. Clin Exp Hypertens. 18:949–961.
Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. (1994) Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 203:719–726.
Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. (1994) Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 201:1160–1166.
Sumimoto T, Nishikimi T, Mukai M, Matsuzaki K, Murakami E, Takishita S, Miyata A, Matsuo H, Kangawa K. (1997) Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension. 30:741–745.
Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H. (1998) Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation. 97:1062–1070.
Tadokoro K, Nishikimi T, Mori Y, Wang X, Akimoto K, Matsuoka H. (2003) Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension. Regul Pept 112:71–78.
Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T. (1998) Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 31:505–510.
Tsuruda T, Kato J, Kitamura K, Kawamoto M, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T.(1999) An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res. 43:958–967.
Yoshibayashi M, Kamiya T, Kitamura K, Saito Y, Kangawa K, Nishikimi T, Matsuoka H, Eto T, Matsuo H. (1997) Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age. Am J Cardiol. 79:1556–1558.
Yoshibayashi M, Kamiya T, Nishikimi T, Saito Y, Matsuo H, Kangawa K. (1999) Elevated plasma levels of adrenomedullin in congenital cyanotic heart disease. Clin Sci 96:543–547.
Yoshitomi Y, Nishikimi T, Kojima S, Kuramochi M, Takishita S, Matsuoka H, Miyata A, Matsuo H, Kangawa K. (1998) Plasma levels of adrenomedullin in patients with acute myocardial infarction. Clin Sci. 94:135–139.
Wang X, Nishikimi T, Akimoto K, Tadokoro K, Mori Y, Minamino N. (2003) Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic. J Hypertens. 21:1171–1181.
Watanabe K, Nishikimi T, Takamuro M, Yasuda K, Ishikawa Y, Tanabe S, Yamada O, Nagaya N, Matsuoka H, Kangawa K, Echigo S. (2003) Two molecular forms of adrenomedullin in congenital heart disease. Pediatr Cardiol. 24:559–565.
Yin H, Chao L, Chao J. (2004) Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension. 43:109–116.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Nishikimi, T. (2005). Circulating Adrenomedullin. In: Nishikimi, T. (eds) Adrenomedullin in Cardiovascular Disease. Basic Science for the Cardiologist, vol 19. Springer, Boston, MA. https://doi.org/10.1007/0-387-25405-6_6
Download citation
DOI: https://doi.org/10.1007/0-387-25405-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25404-3
Online ISBN: 978-0-387-25405-0
eBook Packages: MedicineMedicine (R0)